Firstpath LLC

Firstpath LLC was paid $4.50M by Medicaid between Jan 2018 and Dec 2024, across 182 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 23% of everything it billed.

33Billing provider infoFIRSTPATH LLC
FT LAUDERDALE, FL 33316

33aNPI1720171812assigned 10/02/2006

33bProvider typeAnatomic Pathology & Clinical Pathology Physician

28Total paid$4.50M

24GClaims1,978,672

24DCodes billed182

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida

Rank by total paid#7 of 207

Median peer was paid$39K

This provider vs. median115×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	59,049	$110K
2019	296,916	$963K
2020	268,961	$789K
2021	340,306	$745K
2022	445,836	$615K
2023	373,416	$872K
2024incomplete	194,188	$403K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80053	Comprehensive metabolic panel	23%	182,056	117,371	$1.04M
88305	Level IV - Surgical pathology, gross and microscopic examination	12%	10,386	8,192	$530K
80048	Basic metabolic panel (calcium, ionized)	7.3%	111,772	49,946	$329K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	4.2%	292,298	150,662	$189K
87631		4.2%	14,668	13,642	$189K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	4.0%	35,939	29,761	$179K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	3.3%	20,592	17,496	$151K
87486		3.1%	5,394	5,202	$139K
88307		2.5%	2,422	2,062	$114K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	2.4%	41,803	32,545	$107K
87070		2.3%	27,240	23,253	$104K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.2%	14,577	10,706	$97K

170 more codes

87040		2.1%	39,441	$95K
81001		1.6%	93,783	$71K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	1.4%	9,286	$64K
82948		1.4%	51,778	$62K
84443	Thyroid stimulating hormone (TSH)	1.0%	15,861	$45K
87507		<1%	1,053	$41K
84702		<1%	17,312	$39K
84484		<1%	34,900	$38K
83735		<1%	66,704	$37K
82803		<1%	4,763	$37K
87430		<1%	15,008	$33K
83880		<1%	9,137	$31K
87086	Culture, bacterial; quantitative colony count, urine	<1%	47,811	$27K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	3,561	$22K
82247		<1%	21,116	$21K
86850		<1%	36,215	$20K
88312		<1%	1,980	$19K
85060		<1%	1,860	$19K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	7,280	$18K
80074		<1%	1,678	$18K
83605		<1%	17,974	$17K
81003		<1%	4,800	$17K
82728		<1%	9,437	$16K
85027		<1%	27,076	$16K
87186		<1%	14,542	$16K
84703		<1%	34,972	$15K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	2,247	$15K
88304		<1%	1,066	$15K
87420		<1%	4,946	$14K
83690		<1%	35,715	$14K
80061	Lipid panel	<1%	10,702	$14K
83020		<1%	3,509	$14K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	742	$13K
85730		<1%	36,398	$13K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,011	$13K
86140		<1%	36,943	$13K
86900		<1%	48,056	$12K
80202		<1%	4,872	$11K
85007		<1%	25,180	$11K
88313		<1%	2,591	$10K
86880		<1%	7,669	$10K
85610		<1%	43,471	$10K
86901		<1%	48,032	$10K
88189		<1%	301	$9K
84112		<1%	957	$9K
84100		<1%	29,368	$9K
87077		<1%	10,337	$8K
82550		<1%	19,243	$8K
82607		<1%	5,639	$8K
84145		<1%	5,548	$8K
86902		<1%	2,657	$8K
85055		<1%	2,018	$8K
88342		<1%	509	$8K
85046		<1%	19,688	$7K
86703		<1%	7,442	$7K
87581		<1%	5,387	$7K
82330		<1%	2,131	$5K
86762		<1%	3,544	$5K
83036	Hemoglobin; glycosylated (A1C)	<1%	7,875	$5K
87147		<1%	3,072	$5K
87340		<1%	6,635	$5K
85379		<1%	7,633	$5K
86592		<1%	13,654	$5K
86922		<1%	328	$5K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	3,544	$4K
86885		<1%	4,308	$4K
87150		<1%	388	$4K
82677		<1%	1,673	$4K
81005		<1%	15,778	$4K
87088		<1%	7,150	$3K
88300		<1%	30	$3K
85384		<1%	4,636	$3K
83615		<1%	9,511	$3K
87205		<1%	9,293	$3K
82105		<1%	1,956	$3K
80076		<1%	5,136	$3K
87046		<1%	1,743	$3K
87045		<1%	1,746	$3K
81025		<1%	2,144	$3K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,627	$3K
82746		<1%	2,868	$3K
87536		<1%	296	$3K
84478		<1%	2,600	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,619	$3K
85660		<1%	6,388	$2K
87255		<1%	93	$2K
87210		<1%	5,254	$2K
86905		<1%	2,043	$2K
82378		<1%	991	$2K
87116		<1%	700	$2K
82274		<1%	1,315	$2K
83550		<1%	3,609	$2K
80164		<1%	1,170	$2K
84439		<1%	3,431	$2K
87641		<1%	282	$2K
86803		<1%	842	$2K
83540		<1%	3,904	$2K
82010		<1%	1,731	$1K
82150		<1%	3,577	$1K
82950		<1%	2,632	$1K
86644		<1%	365	$1K
85651		<1%	5,089	$1K
84550		<1%	4,141	$983.77
88112		<1%	112	$906.29
82248		<1%	3,367	$890.67
82570		<1%	2,352	$848.15
84132		<1%	3,533	$826.01
82947		<1%	3,457	$774.71
87015		<1%	596	$637.71
82140		<1%	546	$632.59
82977		<1%	2,148	$630.84
83970		<1%	48	$591.53
87075		<1%	527	$512.56
84156		<1%	1,905	$507.69
80400		<1%	479	$495.88
82951		<1%	252	$433.54
87206		<1%	1,160	$430.36
82533		<1%	329	$429.45
85652		<1%	1,356	$395.51
87449		<1%	130	$388.72
80050	General health panel	<1%	182	$340.57
86308		<1%	790	$338.09
87106		<1%	169	$321.32
88302		<1%	20	$307.73
87184		<1%	868	$294.46
82731		<1%	17	$266.56
87102		<1%	699	$264.49
82945		<1%	483	$230.92
86645		<1%	137	$227.21
87081		<1%	432	$217.74
86870		<1%	100	$178.09
82553		<1%	629	$176.93
86706		<1%	245	$176.56
84436		<1%	472	$147.97
84300		<1%	468	$125.12
86701		<1%	225	$116.71
87324		<1%	195	$107.26
85018		<1%	793	$103.53
82952		<1%	254	$101.24
36415	Collection of venous blood by venipuncture	<1%	345	$96.55
84157		<1%	518	$83.38
86480		<1%	13	$82.60
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	233	$60.00
88141		<1%	14	$56.68
87425		<1%	44	$41.36
86704		<1%	26	$41.11
83930		<1%	83	$37.20
83935		<1%	108	$28.91
87209		<1%	12	$28.57
85520		<1%	60	$28.11
84481		<1%	46	$26.27
83010		<1%	63	$24.22
86708		<1%	29	$22.32
86696		<1%	14	$21.94
82565		<1%	98	$20.06
86778		<1%	14	$14.78
82043		<1%	143	$14.20
84520		<1%	89	$10.92
82962		<1%	23	$10.35
81050		<1%	36	$10.07
84134		<1%	13	$9.96
89051		<1%	118	$3.92
84450		<1%	12	$0.81
84460		<1%	12	$0.71
85014		<1%	19	$0.32
86923		0%	814	$0.00
86336		0%	1,670	$0.00
80329		0%	272	$0.00
86780		0%	42	$0.00
86985		0%	20	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGIFFLER, RONALD (PRESIDENT)